Design of new Mcl-1 inhibitors for cancer using fragments hybridization, molecular docking, and molecular dynamics studies

Author:

Alzain Abdulrahim A.1ORCID,Elbadwi Fatima A.1,Mukhtar Rua M.1,Shoaib Tagyedeen H.1,Abdelmoniem Nihal1,Miski Samar F.2,Ghazawi Kholoud F.3,Alsulaimany Marwa4,Mohamed Shaimaa G. A.5,Ainousah Bayan E.6,Hussein Hazem G. A.7,Mohamed Gamal A.8,Ibrahim Sabrin R. M.910

Affiliation:

1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan

2. Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia

3. Pharmacy Practice Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia

4. Department of Pharmacognosy & Pharmaceutical Chemistry, College of Pharmacy, Taibah University, Medina, Saudi Arabia

5. Faculty of Dentistry, British University, El Sherouk City, Cairo, Egypt

6. Department of Pharmaceutical Sciences, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia

7. Preparatory Year Program, Batterjee Medical College, Jeddah, Saudi Arabia

8. Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia

9. Preparatory Year Program, Department of Chemistry, Batterjee Medical College, Jeddah, Saudi Arabia

10. Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut, Egypt

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3